# Atossa Therapeutics (ATOS) — Analyst Forecast

ATOS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/atos/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 3 | 0 | 0 | 3 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 1, 2026 | Ascendiant Capital | Maintained | Buy | $25.00 |
| Jul 7, 2026 | Rodman & Renshaw | Initiated Coverage | Buy | $12.00 |
| Apr 10, 2026 | Ascendiant Capital | Maintained | Buy | $24.00 |
| Mar 26, 2026 | HC Wainwright & Co. | Maintained | Buy | $25.00 |
| Dec 8, 2025 | Ascendiant Capital | Maintained | Buy | $8.00 |
| Sep 22, 2025 | Ascendiant Capital | Maintained | Buy | $7.75 |
| Jun 6, 2025 | Ascendiant Capital | Maintained | Buy | $7.50 |
| Jun 5, 2025 | Craig-Hallum | Initiated Coverage | Buy | $4.00 |
| Apr 21, 2025 | Ascendiant Capital | Maintained | Buy | $7.25 |
| Mar 26, 2025 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Mar 12, 2025 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Jan 30, 2025 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Dec 13, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Dec 12, 2024 | HC Wainwright & Co. | Maintained | Buy | — |
| Dec 9, 2024 | Ascendiant Capital | Maintained | Buy | $7.00 |
| Nov 13, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Nov 5, 2024 | HC Wainwright & Co. | Maintained | Buy | $6.00 |
| Oct 31, 2024 | HC Wainwright & Co. | Maintained | Buy | $6.00 |
| Sep 11, 2024 | Ascendiant Capital | Maintained | Buy | $6.50 |
| Aug 12, 2024 | HC Wainwright & Co. | Maintained | Buy | $6.00 |

## Frequently Asked Questions

### Is ATOS a buy, sell, or hold?

Analysts covering Atossa Therapeutics currently average a Buy rating: 3 buy, 0 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on ATOS?

On Oct 1, 2026, Ascendiant Capital maintained Atossa Therapeutics at Buy with a price target of $25.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).